Latest news
AstraZeneca (LSE:AZN) Merger Talk Fades, Is The Stock Undervalued? - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 15:16:33 GMTRecon: FDA approves first drug for type 1 narcolepsy, mRNA flu vaccine; No merger talks between AstraZeneca-BMS - RAPSRAPS · Thu, 06 Aug 2026 18:15:00 GMTAstraZeneca, BMS not pursuing merger talks: Reuters - NJBIZNJBIZ · Thu, 06 Aug 2026 17:42:22 GMTAstraZeneca (AZN) Explores Merger Talks with Bristol-Myers Squib - GuruFocusGuruFocus · Thu, 06 Aug 2026 13:52:30 GMTWhat the AstraZeneca-BMS rumors reveal about pharma megamergers - Pharma VoicePharma Voice · Thu, 06 Aug 2026 13:40:22 GMTMergers as Strategic Architecture: Rethinking How to Evaluate the AstraZeneca–BMS Rumors - Pharmaceutical ExecutivePharmaceutical Executive · Thu, 06 Aug 2026 10:02:44 GMTAstraZeneca may buck a decade of pharma strategy to buy U.S. scale - CNBCCNBC · Thu, 06 Aug 2026 09:40:16 GMTAstraZeneca denies media report of merger talks with BMS - medwatch.commedwatch.com · Thu, 06 Aug 2026 06:19:32 GMT